Legend Biotech Corporation logo

Legend Biotech Corporation

LEGN | NASDAQ
Chart Builder DCF Calculator
$18.53
+$0.92 (+5.22%)
At close: Sep 21, 2026, 4:00 PM ET
$18.62
+$0.09 (+0.49%)
Pre-market: Sep 22, 2026, 6:50 AM ET

Market Data

Market Cap
$3.26B
Enterprise Value
$2.74B
Beta
0.40
Average Volume
2.57M
Shares Outstanding (Diluted)
193.8M
Shares Change YoY
5.25%
Institutional Ownership
51.66%
Exchange
NASDAQ
ISIN
US52490G1022

Price Performance

Price Change 1M
-14.4%
Price Change 3M
-36.8%
Price Change 6M
5.3%
Price Change YTD
-13.8%
Price Change 1Y
-45.6%
Price Change 3Y
-70.7%
Price Change 5Y
-60.7%
1M CAGR (ann.)
-8.7%
1Y CAGR (ann.)
-48.9%
5Y CAGR (ann.)
-14.0%
All-Time CAGR
-11.1%

Valuation

PE Ratio
-37.06
Forward PE
28.90
PEG Ratio
-0.43
Forward PEG
0.01
PS Ratio
2.70
Forward PS
1.90
PB Ratio
2.79
P/FCF Ratio
-14.58
P/Adj. FCF Ratio
-12.82
P/OCF Ratio
-18.91
EV/Sales
2.16
EV/EBIT
-63.60
EV/EBITDA
-378.33
EV/FCF
-11.66
Earnings Yield
-2.7%
FCF Yield
-6.9%
Adj. FCF Yield
-7.8%

Financial Health

Net Cash
$808.2M
Total Debt
$278.2M
Cash & Short-Term Investments
$964.6M
Total Assets
$1.75B
Current Ratio
3.04
Quick Ratio
2.94
Debt / Equity Ratio
0.23
Debt / EBITDA
-38.40
Debt / FCF
-1.18
OCF / Debt
-0.66
Interest Coverage
-3.34
Altman Z-Score
3.38
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
56.6%
Operating Profit Margin
-4.4%
EBITDA Margin
-0.6%
Net Profit Margin
-7.2%
FCF Margin
-18.5%
Adj. FCF Margin
-21.0%
SBC / Revenue
2.5%
SBC Impact (per share)
-13.8%

Returns

Return on Assets
-5.2%
Return on Equity
-8.7%
Return on Invested Capital
-3.7%
Return on Capital Employed
-4.2%
Return on Tangible Assets
-5.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
97.7%
Revenue CAGR 5Y
70.3%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
41.6%
EPS CAGR 5Y
32.0%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-15.3%
FCF CAGR 5Y
2.4%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
20
EPS Growth Next 3Y
96.7%
Revenue Growth Next 3Y
20.6%
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
$0.02
EPS Growth Est (next Q)
-118.2%
Revenue Est (next Q)
$361.43M
Revenue Growth Est (next Q)
32.7%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$56.14
Price Target Upside
203.0%

Cash Flow

Operating Cash Flow
$-183.1M
Free Cash Flow
$-234.99M
Adj. Free Cash Flow
$-267.31M
FCF Per Share
-$1.37
OCF Per Share
-$0.98
OCF/S Ratio
-14.4%

Income Statement

Revenue
$1.27B
Gross Profit
$719.24M
Operating Income
$-56.15M
EBITDA
$-7.24M
Net Income
$-91.6M
EPS (Diluted)
-$0.50
Revenue / Employee
$397.28K
Profit / Employee
$-28.63K
Employees
3,200

© 2026 bestshares.com. All rights reserved.